Author contributions AG: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing original draft, Writing review & editing
D., Andersen, D
Huang H, Chen H-W, Evankovich J, Yan W, Rosborough BR, Nace GW, et al
Semaglutide, a long-acting GLP-1 receptor agonist with a half-life of approximately one week, has demonstrated significant efficacy across at least four distinct therapeutic indications, including type 2 diabetes mellitus, chronic weight management in adults with obesity or overweight, reduction of major adverse cardiovascular events in patients with established cardiovascular disease, and emerging indications in metabolic dysfunction-associated steatotic liver disease (MASLD)